4.6 Article

Assessment of Radiologist Performance in the Detection of Lung Nodules: Dependence on the Definition of Truth

期刊

ACADEMIC RADIOLOGY
卷 16, 期 1, 页码 28-38

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.acra.2008.05.022

关键词

Lung nodule; computed tomography (CT); thoracic imaging; interobserver variability; computer-aided diagnosis (CAD)

资金

  1. USPHS [U01CA091085, U01CA091090, U01CA091099, U01CA091100, U01CA091103]

向作者/读者索取更多资源

Rationale and Objectives. Studies that evaluate the lung nodule detection performance of radiologists or computerized methods depend on an initial inventory of the nodules within the thoracic images (the truth). The purpose of this study was to analyze (1) variability in the truth defined by different combinations of experienced thoracic radiologists and (2) variability in the performance of other experienced thoracic radiologists based on these definitions of truth in the context of lung nodule detection in Computed tomographic (CT) scans. Materials and Methods. Twenty-five thoracic CT scans were reviewed by four thoracic radiologists, who independently marked lesions they considered to be nodules >= 3 mm in maximum diameter. Panel truth sets of nodules were then derived from the nodules marked by different combinations of two and three of these four radiologists. The nodule detection performance of the other radiologists was evaluated based on these panel truth sets. Results. The number of true nodules in the different panel truth sets ranged from 15 to 89 (mean 49.8 +/- 25.6). The mean radiologist nodule detection sensitivities across radiologists and panel truth sets for different panel truth conditions ranged from 51.0 to 83.2%: mean false-positive rates ranged from 0.33 to 1.39 per case. Conclusions. Substantial variability exists across radiologists in the task Of hung nodule identification in CT scans. The definition of truth on which lung nodule detection studies are based must be carefully considered, because even experienced thoracic radiologists may not perform well when measured against the truth established by other experienced thoracic radiologists.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Computer Science, Artificial Intelligence

An interpretable deep hierarchical semantic convolutional neural network for lung nodule malignancy classification

Shiwen Shen, Simon X. Han, Denise R. Aberle, Alex A. Bui, William Hsu

EXPERT SYSTEMS WITH APPLICATIONS (2019)

Article Oncology

The Immune Contexture Associates with the Genomic Landscape in Lung Adenomatous Premalignancy

Kostyantyn Krysan, Linh M. Tran, Brandon S. Grimes, Gregory A. Fishbein, Atsuko Seki, Brian K. Gardner, Tonya C. Walser, Ramin Salehi-Rad, Jane Yanagawa, Jay M. Lee, Sherven Sharma, Denise R. Aberle, Arum E. Spira, David A. Elashoff, William D. Wallace, Michael C. Fishbein, Steven M. Dubinett

CANCER RESEARCH (2019)

Editorial Material Oncology

MILD trial, strong confirmation of lung cancer screening efficacy

Matthew B. Schabath, Denise R. Aberle

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Oncology

Micronodules Detected on Computed Tomography During the National Lung Screening Trial: Prevalence and Relation to Positive Studies and Lung Cancer

Reginald F. Munden, Caroline Chiles, Phillip M. Boiselle, JoRean D. Sicks, Denise R. Aberle, Constantine A. Gatsonis

JOURNAL OF THORACIC ONCOLOGY (2019)

Correction Radiology, Nuclear Medicine & Medical Imaging

Toward clinically usable CAD for lung cancer screening with computed tomography (vol 24, pg 2719, 2014)

Matthew S. Brown, Pechin Lo, Jonathan G. Goldin, Eran Barnoy, Grace Hyun J. Kim, Michael F. McNitt-Gray, Denise R. Aberle

EUROPEAN RADIOLOGY (2020)

Article Oncology

Generalizability and Transportability of the National Lung Screening Trial Data: Extending Trial Results to Different Populations

Kosuke Inoue, William Hsu, Onyebuchi A. Arah, Ashley E. Prosper, Denise R. Aberle, Alex A. T. Bui

Summary: This study demonstrates how generalizability and transportability methods can be used to extrapolate treatment effects from different subsets of the population and apply them to target populations. Results show that LDCT screening can significantly reduce lung cancer mortality, with greater effects seen in populations with higher proportions of females and current smokers.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Review Oncology

Patient Adherence to Lung CT Screening Reporting & Data System-Recommended Screening Intervals in the United States: A Systematic Review and Meta-Analysis

Yannan Lin, Mingzhou Fu, Ruiwen Ding, Kosuke Inoue, Christie Y. Jeon, William Hsu, Denise R. Aberle, Ashley Elizabeth Prosper

Summary: This study conducted a systematic review and meta-analysis on patient adherence to Lung-RADS-recommended screening intervals, finding significant heterogeneity in adherence rates between studies, especially among patients with Lung-RADS categories 1 to 2. To improve adherence rates, future research may focus on implementing tailored interventions after identifying barriers to LCS. Additionally, a minimum standardized set of data elements for future pooled analyses of LCS adherence is proposed based on the findings.

JOURNAL OF THORACIC ONCOLOGY (2022)

Article Multidisciplinary Sciences

Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer

Mary L. Stackpole, Weihua Zeng, Shuo Li, Chun-Chi Liu, Yonggang Zhou, Shanshan He, Angela Yeh, Ziye Wang, Fengzhu Sun, Qingjiao Li, Zuyang Yuan, Asli Yildirim, Pin-Jung Chen, Paul Winograd, Benjamin Tran, Yi-Te Lee, Paul Shize Li, Zorawar Noor, Megumi Yokomizo, Preeti Ahuja, Yazhen Zhu, Hsian-Rong Tseng, James S. Tomlinson, Edward Garon, Samuel French, Clara E. Magyar, Sarah Dry, Clara Lajonchere, Daniel Geschwind, Gina Choi, Sammy Saab, Frank Alber, Wing Hung Wong, Steven M. Dubinett, Denise R. Aberle, Vatche Agopian, Steven-Huy B. Han, Xiaohui Ni, Wenyuan Li, Xianghong Jasmine Zhou

Summary: Early cancer detection using cell-free DNA faces challenges of low tumor DNA fraction, molecular heterogeneity, and limited sample sizes. In this study, the authors developed a cost-effective method called cfMethyl-Seq to profile the methylome of cell-free DNA and detect and locate cancer. The approach achieved high sensitivity and accuracy for detecting and identifying the tissue-of-origin of various cancer types.

NATURE COMMUNICATIONS (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Using deep neural networks and interpretability methods to identify gene expression patterns that predict radiomic features and histology in non-small cell lung cancer

Nova F. Smedley, Denise R. Aberle, William Hsu

Summary: Neural networks were trained to predict radiomic features and histology in NSCLC patients, outperforming other classifiers with AUC values ranging from 0.71 to 0.91. Gene masking analysis revealed associations between genes and radiomic features or histology types, demonstrating the ability of neural networks to interpret the models and identify predictive genes.

JOURNAL OF MEDICAL IMAGING (2021)

Proceedings Paper Engineering, Biomedical

EDICNet: An end-to-end detection and interpretable malignancy classification network for pulmonary nodules in computed tomography

Yannan Lin, Leihao Wei, Simon X. Han, Denise R. Aberle, William Hsu

MEDICAL IMAGING 2020: COMPUTER-AIDED DIAGNOSIS (2020)

Meeting Abstract Oncology

Phase I Trial of in Situ Vaccination with Autologous CCL21-Modified Dendritic Cells (CCL21-DC) Combined with Pembrolizumab for Advanced NSCLC

B. Liu, A. Lisberg, R. Salehi-Rad, J. M. Lee, L. M. Tran, K. Krysan, R. Li, R. J. Lim, C. Dumitras, Z. Jing, F. Abtin, R. D. Suh, S. J. Genshaft, S. Oh, D. R. Aberle, L. E. Winter, S. Sharma, D. Elashoff, E. B. Garon, S. M. Dubinett

JOURNAL OF THORACIC ONCOLOGY (2020)

Meeting Abstract Oncology

SGLT2 is a diagnostic target for early stage lung adenocarcinoma

Brendon Villegas, Eva Koziolek, Jie Liu, W. Dean Wallace, David Elashoff, Denise R. Aberle, David B. Shackelford, Jorge R. Barrio, Jane Yanagawa, Steven M. Dubinett, Claudio Scafoglio

CANCER RESEARCH (2019)

Meeting Abstract Oncology

A Phase I trial of in situ vaccination with autologous CCL21-modified dendritic cells (CCL21-DC) combined with pembrolizumab for advanced NSCLC

Bin Liu, Edward B. Garon, Aaron E. Lisberg, Ramin Salehi-Rad, Jay M. Lee, Linh M. Tran, Kostyantyn Krysan, Rui Li, Raymond J. Lim, Manash Paul, Ying Lin, Zhe Jing, Fereidoun Abtin, Robert D. Suh, Scott Oh, Denise R. Aberle, Lauren E. Winter, William Dean Wallace, David Elashoff, Sherven Sharma, Steven M. Dubinett

CANCER RESEARCH (2019)

Article Oncology

Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial

Denise R. Aberle, William C. Black, Caroline Chiles, Timothy R. Church, Ilana F. Gareen, David S. Gierada, Irene Mahon, Eric A. Miller, Paul F. Pinsky, JoRean D. Sicks

JOURNAL OF THORACIC ONCOLOGY (2019)

暂无数据